"ChatGPT Executive Sam Altman Advocates for Psychedelic Revolution"

Sam Altman, CEO of OpenAI and chairman of Journey Colab, is partnering with luxury rehab clinic All Points North to make psychedelic drugs like MDMA and psilocybin available for people with mental health and drug-use disorders. Altman's foray into psychedelics showcases the buzz that the drugs have kindled in Silicon Valley, with venture capitalists betting millions of dollars that such therapies will transform treatment for mental health disorders and drug addiction. Classic psychedelic drugs can retune brain activity by activating receptors for serotonin, a chemical that plays a role in regulating mood, and leaving the brain more open to different perspectives, research shows.